Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Signe Engkjaer, Christensen"'
Autor:
Lene Heickendorff, Signe Engkjaer Christensen, Troels Isaksen, Peter H. Nissen, Christian Stoltz Nielsen, Leif Mosekilde
Publikováno v:
Isaksen, T, Nielsen, C S, Christensen, S E, Nissen, P H, Heickendorff, L & Mosekilde, L 2011, ' Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study ', Calcified Tissue International, vol. 89, no. 4, pp. 285-94 . https://doi.org/10.1007/s00223-011-9517-x
Studies have shown that cancellous bone is relatively preserved in primary hyperparathyroidism (PHPT), whereas bone loss is seen in cortical bone. Familial hypocalciuric hypercalcemia (FHH) patients seem to preserve bone mineral in spite of hypercalc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb5206862a17067edb91f5fc2dd4d301
https://doi.org/10.1007/s00223-011-9517-x
https://doi.org/10.1007/s00223-011-9517-x
Autor:
Signe Engkjaer Christensen, Andrew J Wallace, Leif Mosekilde, Lene Heickendorff, Peter H. Nissen, Kim Brixen
Publikováno v:
Clinical Endocrinology. 72:758-762
Summary Background Mutation screening of the CASR by DNA sequencing is commonly used in the diagnosis of disorders of calcium metabolism, such as familial hypocalciuric hypercalcaemia (FHH). Exon copy number variation is not detected by currently use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e1cc455ed3dd4bc4b696cf4fb5fc9ea
https://doi.org/10.1111/j.1365-2265.2009.03750.x
https://doi.org/10.1111/j.1365-2265.2009.03750.x
Autor:
Peter Vestergaard, Kim Brixen, Leif Mosekilde, Peter H. Nissen, Signe Engkjaer Christensen, Lars Rejnmark, Lene Heickendorff
Publikováno v:
Christensen, S E, Nissen, P H, Vestergaard, P, Heickendorff, L, Rejnmark, L, Brixen, K & Mosekilde, L 2008, ' Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism ', European Journal of Endocrinology, vol. 159, no. 6, pp. 719-27 . https://doi.org/10.1530/EJE-08-0440
IntroductionFamilial hypocalciuric hypercalcemia (FHH) is a lifelong, benign, inherited condition caused by inactivating mutations in the calcium-sensing receptor (CASR) gene. Both FHH and primary hyperparathyroidism (PHPT) are characterized by eleva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d39ca3f1515940ec49cff611948dd04
https://doi.org/10.1530/eje-08-0440
https://doi.org/10.1530/eje-08-0440
Autor:
Signe Engkjaer Christensen, Leif Mosekilde, Kim Brixen, Peter Vestergaard, Peter H. Nissen, Lene Heickendorff
Publikováno v:
Christensen, S E, Nissen, P H, Vestergaard, P, Heickendorff, L, Brixen, K & Mosekilde, L 2008, ' Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism : A follow-up study on methods ', Clinical Endocrinology . https://doi.org/10.1111/j.1365-2265.2008.03259.x
Christensen, S E, Nissen, P H, Vestergaard, P, Heickendorff, L, Brixen, K & Mosekilde, L 2008, ' Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods ', Clinical Endocrinology, vol. 69, no. 5, pp. 713-20 . https://doi.org/10.1111/j.1365-2265.2008.03259.x
Christensen, S E, Nissen, P H, Vestergaard, P, Heickendorff, L, Brixen, K & Mosekilde, L 2008, ' Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods ', Clinical Endocrinology, vol. 69, no. 5, pp. 713-20 . https://doi.org/10.1111/j.1365-2265.2008.03259.x
Udgivelsesdato: 2008-Apr-10 Background: Familial hypocalciuric hypercalcaemia (FHH) must be differentiated from primary hyperparathyroidism (PHPT) since prognosis and treatment differ. In daily practice this discrimination is often based on the renal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::151ba826da88cd8f3b8030de70793f99
https://doi.org/10.1111/j.1365-2265.2008.03259.x
https://doi.org/10.1111/j.1365-2265.2008.03259.x
Autor:
Peter, Vestergaard, Jakob, Starup-Linde, Signe Engkjær, Christensen, Jens Frederik, Dahlerup, Ulla, Bartels, Ole, Færgeman, Ulrik, Gerdes, Stig, Andersen
Publikováno v:
Ugeskrift for laeger. 176(11A)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2abd00715525adc0ae39955eec68f83
https://pubmed.ncbi.nlm.nih.gov/25186722
https://pubmed.ncbi.nlm.nih.gov/25186722
Autor:
Peter Vestergaard, Jakob Starup Linde, Signe Engkjær Christensen, Jens Frederik Dahlerup, Ulla Bartels, Ole Færgeman, Ulrik Gerdes, Stig Andersen
Publikováno v:
Vestergaard, P, Starup-Linde, J, Christensen, S E, Dahlerup, J F, Bartels, U, Færgeman, O, Gerdes, U & Andersen, S 2014, ' Formidling af faglig viden til læger ', Ugeskrift for Laeger, bind 176, nr. 11A .
PURE
Aalborg University
Vestergaard, P, Starup-Linde, J, Christensen, S E, Dahlerup, J F, Bartels, U, Færgeman, O, Gerdes, U & Andersen, S 2014, ' Formidling af faglig viden til læger ', Ugeskrift for Laeger, bind 176, nr. 11A, V65976 .
PURE
Aalborg University
Vestergaard, P, Starup-Linde, J, Christensen, S E, Dahlerup, J F, Bartels, U, Færgeman, O, Gerdes, U & Andersen, S 2014, ' Formidling af faglig viden til læger ', Ugeskrift for Laeger, bind 176, nr. 11A, V65976 .
Statusartikel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4e4492e37c970f5ef7bf7ad92e872b44
https://pure.au.dk/portal/da/publications/formidling-af-faglig-viden-til-laeger(39f34703-cb91-44c7-9816-6cedc18d8fc1).html
https://pure.au.dk/portal/da/publications/formidling-af-faglig-viden-til-laeger(39f34703-cb91-44c7-9816-6cedc18d8fc1).html
Autor:
Søren A. Ladefoged, Kim Brixen, Signe Engkjaer Christensen, Lene Heickendorff, Peter H. Nissen, Leif Mosekilde
Publikováno v:
Nissen, P H, Christensen, S E, Ladefoged, S A, Brixen, K, Heickendorff, L & Mosekilde, L 2012, ' Identification of rare and frequent variants of the CASR gene by high-resolution melting ', Clinica Chimica Acta, vol. 413, no. 5-6, pp. 605-11 . https://doi.org/10.1016/j.cca.2011.12.004
Nissen, P H, Christensen, S E, Ladefoged, S, Brixen, K, Heickendorff, L & Mosekilde, L 2011, ' Identification of rare and frequent variants of the CASR gene by high-resolution melting ', Clinica Chimica Acta, vol. 413, no. 5-6, pp. 605-11 . https://doi.org/10.1016/j.cca.2011.12.004
Nissen, P H, Christensen, S E, Ladefoged, S, Brixen, K, Heickendorff, L & Mosekilde, L 2011, ' Identification of rare and frequent variants of the CASR gene by high-resolution melting ', Clinica Chimica Acta, vol. 413, no. 5-6, pp. 605-11 . https://doi.org/10.1016/j.cca.2011.12.004
Background Calcium metabolic disorders like familial hypocalciuric hypercalcemia (FHH) and autosomal dominant familial isolated hypoparathyroidism (FIH) can be caused by rare variants of the calcium sensing receptor gene (CASR). Molecular genetic scr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8d3afd9fcf712a46ef5654af68a2dee
https://pure.au.dk/portal/da/publications/identification-of-rare-and-frequent-variants-of-the-casr-gene-by-highresolution-melting(5c4bbc9f-f9a6-4108-8786-345999a50319).html
https://pure.au.dk/portal/da/publications/identification-of-rare-and-frequent-variants-of-the-casr-gene-by-highresolution-melting(5c4bbc9f-f9a6-4108-8786-345999a50319).html
Publikováno v:
Christensen, S E, Nissen, P H, Vestergaard, P & Mosekilde, L 2011, ' Familial hypocalciuric hypercalcaemia: a review ', Current Opinion in Endocrinology, Diabetes and Obesity, vol. 18, no. 6, pp. 359-70 . https://doi.org/10.1097/MED.0b013e32834c3c7c
Hypercalcaemia is a potentially life-threatening condition. Familial hypocalciuric hypercalcaemia (FHH) is a rare, lifelong, benign condition. It is important to separate this condition from other hypercalcaemic states such as hypercalcaemia of malig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e10365566fa897a79016c00f0fb8b564
https://pubmed.ncbi.nlm.nih.gov/21986511
https://pubmed.ncbi.nlm.nih.gov/21986511
Autor:
Peter Vestergaard, Kim Brixen, Peter H. Nissen, Leif Mosekilde, Signe Engkjaer Christensen, Lene Heickendorff, Lars Rejnmark
Publikováno v:
Christensen, S E, Nissen, P H, Vestergaard, P, Heickendorff, L, Rejnmark, L, Brixen, K & Mosekilde, L 2009, ' Skeletal consequences of familial hypocalciuric hypercalcaemia versus primary hyperparathyroidism ', Clinical Endocrinology, vol. 71, pp. 798-807 . https://doi.org/10.1111/j.1365-2265.2009.03557.x
Christensen, S E, Nissen, P H, Vestergaard, P, Heickendorff, L, Rejnmark, L, Brixen, K & Mosekilde, L 2009, ' Skeletal consequences of familiar hypocalciuric hypercalcaemia versus primary hyperparathyroidism ', Clinical Endocrinology, vol. 71, no. 6, pp. 798-807 . https://doi.org/10.1111/j.1365-2265.2009.03557.x
Christensen, S E, Nissen, P H, Vestergaard, P, Heickendorff, L, Rejnmark, L, Brixen, K & Mosekilde, L 2009, ' Skeletal consequences of familiar hypocalciuric hypercalcaemia versus primary hyperparathyroidism ', Clinical Endocrinology, vol. 71, no. 6, pp. 798-807 . https://doi.org/10.1111/j.1365-2265.2009.03557.x
Summary Objectives Bone metabolism is only superficially described in familiar hypocalciuric hypercalcaemia (FHH). We describe and compare biochemical and osteodensitometric variables in FHH and primary hyperparathyroidism (PHPT) and assess whether t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71dc795150e21fbb869604eb07c9f3c3
https://portal.findresearcher.sdu.dk/da/publications/a1bf3b50-2c25-11de-ae62-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/a1bf3b50-2c25-11de-ae62-000ea68e967b
Autor:
Bjarke Moosgaard, Peer Christiansen, P. Vestergaard, Signe Engkjaer Christensen, Lis Mosekilde, Lene Heickendorff
Publikováno v:
Moosgaard, B, Christensen, S E, Vestergaard, P, Heickendorff, L, Christiansen, P M & Mosekilde, L 2007, ' Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism ', Clinical Endocrinology, vol. 68, no. 5, pp. 707-15 . https://doi.org/10.1111/j.1365-2265.2007.03109.x
Moosgaard, B, Christensen, S E, Vestergaard, P, Heickendorff, L, Christiansen, P M & Mosekilde, L 2008, ' Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism ', Clinical Endocrinology, vol. 68, pp. 707-715 . https://doi.org/10.1111/j.1365-2265.2007.03109.x
Moosgaard, B, Christensen, S E, Vestergaard, P, Heickendorff, L, Christiansen, P M & Mosekilde, L 2008, ' Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism ', Clinical Endocrinology, vol. 68, pp. 707-715 . https://doi.org/10.1111/j.1365-2265.2007.03109.x
Udgivelsesdato: 2008-May BACKGROUND: Primary hyperparathyroidism (PHPT) is associated with reduced bone mineral density (BMD) mainly at sites rich in cortical bone. However, successful parathyroidectomy causes an increase in BMD especially at sites r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda4addd5abe71a2dc381cc7718f07a9
https://pubmed.ncbi.nlm.nih.gov/17980013
https://pubmed.ncbi.nlm.nih.gov/17980013